Germline BRCA-Mutated HER2-Negative Metastatic Breast Cancer

What are the types of metastatic breast cancer (MBC)?

Breast cancer is a type of cancer that starts in the breast. It can start in one or both breasts, and it is the most common cancer in women in the US, excluding skin cancer. If the breast cancer is metastatic, it means it has spread to other parts of the body and is no longer only in the breast area. 

There are several types of breast cancer that can metastasize. More breast cancers start in the ducts or lobules and are called:

  • Invasive ductal carcinomas, which start in the cells lining the milk ducts and make up the majority of breast cancers
  • Invasive lobular carcinomas, which start in the lobules—small, tube-like structures that contain milk glands 

Testing may be done to determine breast cancer subtypes such as:

  • Hormone receptor-positive or -negative—determines whether cells have proteins that are estrogen receptor (ER) or progesterone receptor (PR)
  • HER2-positive—have many copies of the HER2 gene or high levels of HER2 protein, which is essential for tumor cell growth
  • HER2-negative—has little to no HER2 protein
    • HER2-low–low level of HER2 on the cancer cells but not enough HER2 to be considered HER2-positive

  • Triple-negative—Triple-negative breast cancer (TNBC) doesn’t have estrogen or progesterone receptors and also makes too little or none of the HER2 protein

6%

of women in the US have metastatic breast cancer when they are first diagnosed

What is germline BRCA-mutated HER2-negative metastatic breast cancer?

Certain gene mutations that increase the risk of breast cancer can be passed from either a mother and/or a father to children. Inherited Breast Cancer gene mutations (also written as “inherited BRCA mutations”) are changes to the BRCA gene that can increase your risk of developing breast cancer and contribute to cancer cell growth. BRCA1 and BRCA2 are the most well-known gene mutations and can greatly increase your risk of breast cancer and other cancers. In normal cells, the BRCA protein works to repair cell damage but does not work properly if you have a BRCA mutation.

HER2-negative (human epidermal growth factor receptor 2-negative) means that the breast cancer cells have a small amount of or no protein called HER2 on their surface. In normal cells, HER2 helps control cell growth. HER2-negative breast cancer can either be hormone receptor-positive or triple-negative. 

Risk factors

Risk factors for developing breast cancer include:

  • Sex: women are much more likely than men to develop breast cancer

  • Aging

  • Personal and family history of breast cancer

  • Inherited genes that increase cancer risk

  • Radiation exposure

  • Obesity

  • Beginning period before age 12

  • Beginning menopause at an older age

  • Having a first child after age 30

  • Having never been pregnant

  • Receiving postmenopausal hormone therapy

  • Alcohol use

Please note that the risk factors listed above are not exhaustive.

Online Support

You don’t have to face cancer alone. Explore our list of AstraZeneca and independent resources to find a community you can connect with.

YOUR Cancer

A community engagement and recognition program that catalyzes diverse organizations and individuals across public health and oncology to bring about meaningful change.

Living Beyond Breast Cancer

Living Beyond Breast Cancer provides programs and services to help people whose lives have been impacted by breast cancer. Their goal is to provide information, community, and support that you can trust.

SHARE

A national nonprofit organization that supports, educates, and empowers women affected by breast or ovarian cancer, with a special focus on medically underserved communities. SHARE’s free services, provided in both English and Spanish, include support groups, educational programs, a national helpline, community outreach, online communities, corporate education programs, advocacy opportunities, caregiver support, and survivor-patient navigation.

METAvivor

The first organization dedicated to funding research for Stage IV breast cancer, METAvivor continues to rally public awareness, award research grants, and provide much needed support for those living with MBC.